These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 18442126)

  • 1. Potassium channel blocker 4-aminopyridine is effective in interictal cerebellar symptoms in episodic ataxia type 2--a video case report.
    Löhle M; Schrempf W; Wolz M; Reichmann H; Storch A
    Mov Disord; 2008 Jul; 23(9):1314-6. PubMed ID: 18442126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aminopyridines for the treatment of cerebellar and ocular motor disorders.
    Strupp M; Kalla R; Glasauer S; Wagner J; Hüfner K; Jahn K; Brandt T
    Prog Brain Res; 2008; 171():535-41. PubMed ID: 18718350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine.
    Strupp M; Kalla R; Dichgans M; Freilinger T; Glasauer S; Brandt T
    Neurology; 2004 May; 62(9):1623-5. PubMed ID: 15136697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of 3,4-diaminopyridine on the patients with hereditary pure cerebellar ataxia.
    Tsunemi T; Ishikawa K; Tsukui K; Sumi T; Kitamura K; Mizusawa H
    J Neurol Sci; 2010 May; 292(1-2):81-4. PubMed ID: 20181362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of regularity and synchrony of cerebellar Purkinje cells for pathological nystagmus.
    Glasauer S; Rössert C; Strupp M
    Ann N Y Acad Sci; 2011 Sep; 1233():162-7. PubMed ID: 21950989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-aminopyridine and cerebellar gait: a retrospective case series.
    Schniepp R; Wuehr M; Neuhaeusser M; Benecke AK; Adrion C; Brandt T; Strupp M; Jahn K
    J Neurol; 2012 Nov; 259(11):2491-3. PubMed ID: 22760944
    [No Abstract]   [Full Text] [Related]  

  • 7. 4-aminopyridine restores vertical and horizontal neural integrator function in downbeat nystagmus.
    Kalla R; Glasauer S; Büttner U; Brandt T; Strupp M
    Brain; 2007 Sep; 130(Pt 9):2441-51. PubMed ID: 17664175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on the Pharmacotherapy of Cerebellar Ataxia and Nystagmus.
    Feil K; Bremova T; Muth C; Schniepp R; Teufel J; Strupp M
    Cerebellum; 2016 Feb; 15(1):38-42. PubMed ID: 26519380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hereditary episodic ataxia].
    Riant F; Vahedi K; Tournier-Lasserve E
    Rev Neurol (Paris); 2011 May; 167(5):401-7. PubMed ID: 21492892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysfunction of the brain calcium channel CaV2.1 in absence epilepsy and episodic ataxia--a comment.
    Strupp M; Kalla R; Freilinger T; Dichgans M; Brandt T
    Brain; 2005 Jun; 128(Pt 6):E32; author reply E33. PubMed ID: 15900025
    [No Abstract]   [Full Text] [Related]  

  • 11. The therapeutic mode of action of 4-aminopyridine in cerebellar ataxia.
    Alviña K; Khodakhah K
    J Neurosci; 2010 May; 30(21):7258-68. PubMed ID: 20505092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of spinocerebellar ataxia type 6 with its initial symptom of episodic ataxia-like phenotype].
    Shimazaki H; Nakao K; Ishikawa K; Takiyama Y; Nakano I
    No To Shinkei; 2006 Jan; 58(1):63-7. PubMed ID: 16482924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with 4-aminopyridine improves upper limb tremor of a patient with multiple sclerosis: a video case report.
    Schniepp R; Jakl V; Wuehr M; Havla J; Kümpfel T; Dieterich M; Strupp M; Jahn K
    Mult Scler; 2013 Apr; 19(4):506-8. PubMed ID: 23069878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel CACNA1A mutation causes febrile episodic ataxia with interictal cerebellar deficits.
    Subramony SH; Schott K; Raike RS; Callahan J; Langford LR; Christova PS; Anderson JH; Gomez CM
    Ann Neurol; 2003 Dec; 54(6):725-31. PubMed ID: 14681882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can 4-aminopyridine modulate dysfunctional gait networks in Parkinson's disease?
    Luca CC; Singer C
    Parkinsonism Relat Disord; 2013 Sep; 19(9):777-82. PubMed ID: 23706539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early-onset progressive ataxia associated with the first CACNA1A mutation identified within the I-II loop.
    Cricchi F; Di Lorenzo C; Grieco GS; Rengo C; Cardinale A; Racaniello M; Santorelli FM; Nappi G; Pierelli F; Casali C
    J Neurol Sci; 2007 Mar; 254(1-2):69-71. PubMed ID: 17292920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potassium channel antagonists 4-aminopyridine and the T-butyl carbamate derivative of 4-aminopyridine improve hind limb function in chronically non-ambulatory dogs; a blinded, placebo-controlled trial.
    Lim JH; Muguet-Chanoit AC; Smith DT; Laber E; Olby NJ
    PLoS One; 2014; 9(12):e116139. PubMed ID: 25551385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on the pharmacotherapy of cerebellar and central vestibular disorders.
    Kalla R; Teufel J; Feil K; Muth C; Strupp M
    J Neurol; 2016 Apr; 263 Suppl 1():S24-9. PubMed ID: 27083881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of piracetam on ataxia: clinical observations in a group of autosomal dominant cerebellar ataxia patients.
    Ince Gunal D; Agan K; Afsar N; Borucu D; Us O
    J Clin Pharm Ther; 2008 Apr; 33(2):175-8. PubMed ID: 18315783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias.
    Strupp M; Kalla R; Claassen J; Adrion C; Mansmann U; Klopstock T; Freilinger T; Neugebauer H; Spiegel R; Dichgans M; Lehmann-Horn F; Jurkat-Rott K; Brandt T; Jen JC; Jahn K
    Neurology; 2011 Jul; 77(3):269-75. PubMed ID: 21734179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.